UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 155

Sortiert nach

Constructing Experimental Designs for Discrete-Choice Experiments: Report of the ISPOR Conjoint Analysis Experimental Design Good Research Practices Task Force

Value in health, 2013-01, Vol.16 (1), p.3-13

2013

Link zum Volltext

Verfügbarkeit prüfen

Conjoint Analysis Applications in Health—a Checklist: A Report of the ISPOR Good Research Practices for Conjoint Analysis Task Force

Value in health, 2011-06, Vol.14 (4), p.403-413

2011

Link zum Volltext

Verfügbarkeit prüfen

Genetic matching for time-dependent treatments: a longitudinal extension and simulation study

BMC medical research methodology, 2023-08, Vol.23 (1), p.181-181, Article 181

2023

Link zum Volltext

Verfügbarkeit prüfen

Describing practices of priority setting and resource allocation in publicly funded health care systems of high-income countries

BMC health services research, 2021-01, Vol.21 (1), p.90-90, Article 90

2021

Link zum Volltext

Verfügbarkeit prüfen

FDA Accelerated Approval for Malignant Hematology and Oncology Indications in the Canadian Environment

Current oncology (Toronto), 2022-01, Vol.29 (2), p.402-410

2022

Link zum Volltext

Verfügbarkeit prüfen

Genetic testing for hereditary cancer syndromes: patient recommendations for improved risk communication

Health expectations : an international journal of public participation in health care and health policy, 2020-08, Vol.23 (4), p.884-892

2020

Link zum Volltext

Verfügbarkeit prüfen

Development and early‐stage evaluation of a patient portal to enhance familial communication about hereditary cancer susceptibility testing: A patient‐driven approach

Health expectations : an international journal of public participation in health care and health policy, 2023-04, Vol.26 (2), p.774-784

2023

Link zum Volltext

Verfügbarkeit prüfen

Public perspectives on disinvestments in drug funding: results from a Canadian deliberative public engagement event on cancer drugs

BMC public health, 2019-07, Vol.19 (1), p.977-977, Article 977

2019

Link zum Volltext

Verfügbarkeit prüfen

Cost-Effectiveness Analysis of Stereotactic Ablative Body Radiotherapy for the Treatment of Oligometastatic Tumors versus Standard of Care

Current oncology (Toronto), 2021-05, Vol.28 (3), p.1857-1866

2021

Link zum Volltext

Verfügbarkeit prüfen

Stakeholder Perspectives on Navigating Evidentiary and Decision Uncertainty in Precision Oncology

Journal of personalized medicine, 2022-01, Vol.12 (1), p.22

2022

Link zum Volltext

Verfügbarkeit prüfen

A perspective on life-cycle health technology assessment and real-world evidence for precision oncology in Canada

NPJ precision oncology, 2022-10, Vol.6 (1), p.76-76, Article 76

2022

Link zum Volltext

Verfügbarkeit prüfen

Cost-Effectiveness of Molecularly Guided Treatment in Diffuse Large B-Cell Lymphoma (DLBCL) in Patients under 60

Cancers, 2022-02, Vol.14 (4), p.908

2022

Link zum Volltext

Verfügbarkeit prüfen

Balancing uncertainty with patient autonomy in precision medicine

Nature reviews. Genetics, 2019-05, Vol.20 (5), p.251

2019

Link zum Volltext

Verfügbarkeit prüfen

The Past, Present, and Future of Economic Evaluations of Precision Medicine at the Committee for Economic Analyses of the Canadian Cancer Trials Group

Current oncology (Toronto), 2021-09, Vol.28 (5), p.3649-3658

2021

Link zum Volltext

Verfügbarkeit prüfen

Discrete choice experiment to evaluate factors that influence preferences for antibiotic prophylaxis in pediatric oncology

PloS one, 2012-10, Vol.7 (10), p.e47470-e47470

2012

Link zum Volltext

Verfügbarkeit prüfen

Developing Data Sharing Models for Health Research with Real-World Data: A Scoping Review of Patient and Public Preferences

Journal of medical systems, 2022-10, Vol.46 (12), p.86-86, Article 86

2022

Link zum Volltext

Verfügbarkeit prüfen

Choice certainty and deliberative thinking in discrete choice experiments. A theoretical and empirical investigation

Journal of economic behavior & organization, 2019-08, Vol.164, p.235-255

2019

Link zum Volltext

Verfügbarkeit prüfen

Matching methods in precision oncology: An introduction and illustrative example

Molecular genetics & genomic medicine, 2021-01, Vol.9 (1), p.e1554-n/a

2021

Link zum Volltext

Verfügbarkeit prüfen

Clinical and cost outcomes following genomics‐informed treatment for advanced cancers

Cancer medicine (Malden, MA), 2021-08, Vol.10 (15), p.5131-5140

2021

Link zum Volltext

Verfügbarkeit prüfen

Toward best practices for economic evaluations of tumour-agnostic therapies: A review of current barriers and solutions

Value in health, 2023-11, Vol.26 (11), p.1608-1617

2023

Link zum Volltext

Verfügbarkeit prüfen

The EORTC QLU-C10D: The Canadian Valuation Study and Algorithm to Derive Cancer-Specific Utilities From the EORTC QLQ-C30

MDM policy & practice, 2019, Vol.4 (1), p.2381468319842532-2381468319842532

2019

Link zum Volltext

Verfügbarkeit prüfen

The Girls-Only HPV Vaccination Program in British Columbia, Canada: A Qualitative Study Exploring Expert Informants' Perspectives of Input From the Public

Journal of obstetrics and gynaecology Canada, 2017-09, Vol.39 (9), p.726-727

2017

Link zum Volltext

Verfügbarkeit prüfen

Valuation of Health and Nonhealth Outcomes from Next-Generation Sequencing: Approaches, Challenges, and Solutions

Value in health, 2018-09, Vol.21 (9), p.1043-1047

2018

Link zum Volltext

Verfügbarkeit prüfen

Utility maximization versus regret minimization in health choice behavior: Evidence from four datasets

Health economics, 2022-02, Vol.31 (2), p.363-381

2022

Link zum Volltext

Verfügbarkeit prüfen

Preferences for Prostate Cancer Outcomes: A Comparison of the Patient Perspective, the General Population Perspective, and a Population at Risk for Prostate Cancer

Value in health, 2016-03, Vol.19 (2), p.218-225

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 155

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(142)
Mit Volltextzugriff
(141)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Constructing Experimental Designs for Discrete-Choice Experiments: Report of the ISPOR Conjoint Analysis Experimental Design Good Research Practices Task Force

Conjoint Analysis Applications in Health—a Checklist: A Report of the ISPOR Good Research Practices for Conjoint Analysis Task Force

Genetic matching for time-dependent treatments: a longitudinal extension and simulation study

Describing practices of priority setting and resource allocation in publicly funded health care systems of high-income countries

FDA Accelerated Approval for Malignant Hematology and Oncology Indications in the Canadian Environment

Genetic testing for hereditary cancer syndromes: patient recommendations for improved risk communication

Development and early‐stage evaluation of a patient portal to enhance familial communication about hereditary cancer susceptibility testing: A patient‐driven approach

Public perspectives on disinvestments in drug funding: results from a Canadian deliberative public engagement event on cancer drugs

Cost-Effectiveness Analysis of Stereotactic Ablative Body Radiotherapy for the Treatment of Oligometastatic Tumors versus Standard of Care

Stakeholder Perspectives on Navigating Evidentiary and Decision Uncertainty in Precision Oncology

A perspective on life-cycle health technology assessment and real-world evidence for precision oncology in Canada

Cost-Effectiveness of Molecularly Guided Treatment in Diffuse Large B-Cell Lymphoma (DLBCL) in Patients under 60

Balancing uncertainty with patient autonomy in precision medicine

The Past, Present, and Future of Economic Evaluations of Precision Medicine at the Committee for Economic Analyses of the Canadian Cancer Trials Group

Discrete choice experiment to evaluate factors that influence preferences for antibiotic prophylaxis in pediatric oncology

Developing Data Sharing Models for Health Research with Real-World Data: A Scoping Review of Patient and Public Preferences

Choice certainty and deliberative thinking in discrete choice experiments. A theoretical and empirical investigation

Matching methods in precision oncology: An introduction and illustrative example

Clinical and cost outcomes following genomics‐informed treatment for advanced cancers

Toward best practices for economic evaluations of tumour-agnostic therapies: A review of current barriers and solutions

The EORTC QLU-C10D: The Canadian Valuation Study and Algorithm to Derive Cancer-Specific Utilities From the EORTC QLQ-C30

The Girls-Only HPV Vaccination Program in British Columbia, Canada: A Qualitative Study Exploring Expert Informants' Perspectives of Input From the Public

Valuation of Health and Nonhealth Outcomes from Next-Generation Sequencing: Approaches, Challenges, and Solutions

Utility maximization versus regret minimization in health choice behavior: Evidence from four datasets

Preferences for Prostate Cancer Outcomes: A Comparison of the Patient Perspective, the General Population Perspective, and a Population at Risk for Prostate Cancer

Suchergebnisse filtern